Liposome-encapsulated antimicrobial peptides: Potential infectious diseases therapy

Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering

Volumn , Issue , 2014, Pages 301-332

  Gupta, Anju ^a   Gupta, Reetu ^b   Kurwardkar, Sudarshan ^c  

^a ROSE HULMAN INSTITUTE OF TECHNOLOGY   (United States)

^b LSU Health Shreveport   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; LIPOSOMES; PEPTIDES;

ANTIMICROBIAL PEPTIDE; ANTIMICROBIAL RESISTANCES; ANTIMICROBIAL THERAPY; BIOPHYSICAL TECHNIQUES; INFECTIOUS DISEASE; MEMBRANE BINDING; MODEL MEMBRANES;

MICROORGANISMS;

EID: 84945325370     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4018/978-1-4666-6363-3.ch014     Document Type: Chapter

References (133)

1. Agirre, A., Flach, C., Goni, F. M., Mendelsohn, R., Valpuesta, J. M., Wu, F., & Nieva, J. L. (2000). Interactions of the HIV-1 fusion peptide with large unilamellar vesicles and monolayers.A cryo-TEM and spectroscopic study. Biochimica et Biophysica Acta, 1467(1), 153-164. doi: 10.1016/S0005-2736(00)00214-5 PMID:10930518
2. Ahmad, I., Perkins, W. R., Lupan, D. M., Selsted, M. E., & Janoff, A. S. (1995). Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antiungal activity. Biochimica et Biophysica Acta, 1237(2), 109-114. doi: 10.1016/0005-2736(95)00087-J PMID:7632702
3. Alipour,M., Halwani,M., Omri,A., Suntres,Z.E. (2008). Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains, 355, 293-298.
4. Allen, T. M., & Cullis, P. R. (2004). Drug delivery systems: Entering the main stream. Science, 303(5665), 1818-1822. doi: 10.1126/science.1095833 PMID:15031496
5. Allison, A. G., & Gregoriadis, G. (1974). Liposomes as immunolgical adjuvants. Nature, 252(5480), 252. doi: 10.1038/252252a0 PMID:4424229
6. Almgren, M., Edwards, K., & Karlsson, G. (2000). Cryo transmission electron microscopy of liposomes and related structures. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 174(1-2), 3-21. doi: 10.1016/S0927-7757(00)00516-1
7. Alpar, H. O., Bowen, J. C., & Brown, M. R. W. (1992). Effectiveness of liposomes as adjuvants or orally and nasally administarted tetanus toxoid. International Journal of Pharmaceutics, 88(1-3), 335-344. doi: 10.1016/0378-5173(92)90332-V
8. Marshall, T.G. (2006). Amino acid size, charge, hydrophpbicity indices and matrices for protein structure analysis. Theoretical Biology & Medical Modelling, 3(15), 1-12. PubMed PMID:16403216
9. Amselem, S., Gabizon, A., & Barenholz, Y. (1993). (. A large scale method for the preparation of sterile and non-pyrogenic formulations of defined size distributions for clinical use. Liposome Technology, 1, 501-525.
10. Antimicrobial Peptide Database. (2014). Retrieved from http://aps.unmc.edu/AP/main.php Accessed 03/24/2014
11. Audouy, S. A. L., de Leij, L. F. M. H., Hoekstra, D., & Molema, G. (2002). In vivo characteristics of cationic liposomes a delivery vectors for gene therapy. Pharmaceutical Research, 19(11), 1599-1605. doi: 10.1023/A:1020989709019 PMID:12458664
12. Bachmann, M. F., & Jennings, G. T. (2010). Vaccine delivery: A matter of size, geometry,kinectis and molecular patterns. Nature reviews. Immunology, 10, 787-796. PMID:20948547
13. Bangham, A. D. (1980). Development of the liposome concept. Liposomes in Biological Systems. Chichester: John Wiley and Sons.
14. Bédoyère, G. D. (2005). The discovery of Penicillin. Evans Brothers Ltd.
15. Bellare, J. R., Davis, L. E., Scriven, L. E., & Talmon, Y. (1988). Controlled environment vitrification system: An improved sample preparation technique. Journal of Electron Microscopy Technique, 10(1), 87-111. doi: 10.1002/jemt.1060100111 PMID:3193246
16. Binder, W. H., Barragan, V., & Menger, F. M. (2003). Domains and rafts in lipid membranes. Angewandte Chemie (International ed. in English), 42(47), 5802-5827. doi: 10.1002/anie.200300586 PMID:14673910
17. Borenstain, V., & Barenholz, Y. (1993). Characterization of liposomes and other lipid assemblies by microprobe fluorescence polarization. Chemistry and Physics of Lipids, 64(1-3), 117-127. doi: 10.1016/0009-3084(93)90061-7 PMID:8242830
18. Bothun, G. D., Knutson, B. L., Strobel, H. J., & Nokes, S. E. (2005). Liposome fluidization and melting point depression by pressurized CO2 determined by fluorescence anisotropy. Langmuir, 21(2), 530-536. doi: 10.1021/la0496542 PMID:15641820
19. Boulikas, T. (2009). Clinical overview of lipoplatin: A successful liposomal formulation of cisplatin. Expert Opinion on Investigational Drugs, 18(8), 1197-1218. doi: 10.1517/13543780903114168 PMID:19604121
20. Brogden, K. A. (2005 ). Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature reviews. Microbiology, 3, 238-250. PMID:15703760
21. Butts, C., Murray, N., Davis, M., Smith, C., Ellis, P., & Plamer, M. (2005). Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23(27), 6674-6681. doi: 10.1200/JCO.2005.13.011 PMID:16170175
22. Carmona-Ribeiro, A. M. (2001). Bilayer vesicles and liposomes as interface agents. Chemical Society Reviews, 30(4), 241-247. doi: 10.1039/b101608n
23. Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006). Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochimica et Biophysica Acta, 1758(9), 1184-202. PMID:16756942
24. Chen, C., Han, D., Cai, C., & Tang, X. (2010). An overview of liposome lyophilization and its future potential. Journal of Controlled Release, 142(3), 299-311. doi: 10.1016/j.jconrel.2009.10.024 PMID:19874861
25. Cherkasov, A., Hilpert, K., Jenssen, H., & Hancock, R. E. W. (2009). Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad Spectrum of Highly Antibiotic-Resistant Superbugs. ACS chemical biology, 4(1), 65-74. PMID:19055425
26. Choi, J. S., Lee, E. J., Jang, H. S., & Park, J. S. (2001). New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjugate Chemistry, 12(1), 108-113. doi: 10.1021/bc000081o PMID:11170373
27. Chu, B. (1974). Laser Light Scattering. New York: Academic press.
28. Constantinescu, I., Levin, E., & Gyongyossy-Issa, M. (2003). Liposomes and blood cells: A flow cytometric study. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 31(4), 395-424. doi: 10.1081/BIO-120025410 PMID:14672416
29. Davis, D., & Gregoriadis, G. (1987). Liposomes as adjuvants with immunopurified tetanus toxoid: Influence of liposomal characteristics. Immunology, 61(2), 229-234. PMID:3596639
30. de la Maza, A., & Parra, J. L. (1996). Assembly properties of Triton X-100/phosphatidylcholine aggregates during liposome solubilization. Colloid & Polymer Science, 274(9), 866-874. doi: 10.1007/BF00654745
31. de Lima, M., Neves, S., Filipe, A., Duzgunes, N., & Simoes, S. (2003). Cationic liposomes for gene delivery:from biophysics to biological applications. Current Medicinal Chemistry, 10(14), 1221-1231. doi: 10.2174/0929867033457430 PMID:12678796
32. Deshayes, S., Heitz, A., Morris, M. C., Charnet, P., Divita, G., & Heitz, F. (2004). Insight into the Mechanism of Internalization of the Cell-Penetrating Carrier Peptide Pep-1 through Conformational Analysis. Biochemistry, 43(6), 1449-457. doi: 10.1021/bi035682s PMID:14769021
33. Deshayes, S., Plenat, T., Charnet, P., Divita, G., Molle, G., & Heitz, F. (2006). Formation of transmembrane ionic channels of pr The interactions of antimicrobial peptides derived from imary amphiphatic cell-penetrating peptides.Consequences on the mechanism of cell penetration. Biochimica et Biophysica Acta, 1758, 46-51.
34. Dietz, G. P., & Bahr, M. (2005). Peptideenhanced cellular internalization of proteins in neuroscience. Brain Research Bulletin, 68(1-2), 103-114. doi: 10.1016/j.brainresbull.2005.08.015 PMID:16325010
35. Drin, G., & Temsamani, J. (2002). Translocation of protegrin I through phospholipid membrane: Role of peptide folding. Biochimica et Biophysica Acta, 1559(2), 160-170. doi: 10.1016/S0005-2736(01)00447-3 PMID:11853682
36. Edelman, R. (1980). Vaccine adjuvants. Reviews of infectious diseases, 2(3), 370-383. doi: 10.1093/clinids/2.3.370 PMID:6997966
37. Ellens, H., Bentz, J., & Szoka, F. C. (1986). Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature. Biochemistry, 25(2), 285-294. doi: 10.1021/bi00350a001 PMID:3954998
38. Engler, A. C., Tan, J. P. K., Ong, Z. Y., Coady, D. J., Ng, V. W. L., Yang, Y. Y., & Hedrick, J. L. (2013). Antimicrobial polycarbonates: Investigating the impact of balancing charge and hydrophobicity using a same-centered polymer approach. Biomacromolecules, 14(12), 4331-4339. doi: 10.1021/bm401248t PMID:24228904
39. Fahr, A., Hoogevest, P., May, S., Bergstrand, N., & S. Leigh, M. L. (2005, November). Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery. European Journal of Pharmaceutical Sciences, 26(3-4), 251-265. doi: 10.1016/j.ejps.2005.05.012 PMID:16112849
40. Farokhzad, O. C., & Langer, R. (2006). Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Advanced Drug Delivery Reviews, 58(14), 1456-1459. doi: 10.1016/j.addr.2006.09.011 PMID:17070960
41. Fjell, C.D., Hiss, J.A., & Hancock, R.E.W. & Schneider. (2012). Designing antimicrobial peptides: Form follows function. Nature reviews. Drug discovery, 11, 37-51. PMID:22173434
42. Futaki, S. (2002). Arginine-rich peptides: Potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. International journal of pharmaceutics, 245(1-2), 1-7. doi: 10.1016/S0378-5173(02)00337-X PMID:12270237
43. Gabizon, A., Shmeeda, H., Horowitz, A. T., & Zalipsky, S. (2004). Tumor cells targeting of liposome-entrapped drugs with phospholipidanchored folic acid-PEG conjugates. Advanced Drug Delivery Reviews, 56(8), 1177-1192. doi: 10.1016/j.addr.2004.01.011 PMID:15094214
44. Garbuzenko, O., Barenholz, Y., & Priev, A. (2005). Effect of grafted PEG on liposome size and on comressibility and packing of lipid bilayer. Chemistry and Physics of Lipids, 135(2), 117-129. doi: 10.1016/j.chemphyslip.2005.02.003 PMID:15921973
45. Gershoni, J. M., Berman, R., Siman-Tov, R., & Yael, W. (2007). Epitope-mapping the first step in developing epitope-based vaccines. Bio-Drugs, 21(3), 145-156. doi: 10.2165/00063030-200721030-00002 PMID:17516710
46. Gregoriadis, G., Saffle, R., & Hart, S. L. (1996). High yield incorporation of plasmid DNA within liposomes:effect on DNA integrity and transfection efficiency. Journal of Drug Targeting, 3(6), 469-475. doi: 10.3109/10611869609015966 PMID:8863139
47. Guerra, E., Mendoza, T., Reyes, S. O., & Teran, L. M. (2010). Antimicrobial peptides: General overview and clinical implications in human health and disease. Clinical Immunology (Orlando, Fla.), 135(1), 1-11. doi: 10.1016/j.clim.2009.12.004 PMID:20116332
48. Gupta, A., Mandal, D., Ahmadibeni, Y., Parang, K., & Bothun, G. (2011). Hydrophobicity drives the cellular uptake of short cationic peptide ligands. European Biophysics Journal, 40(6), 727-736. doi: 10.1007/s00249-011-0685-4 PMID:21409455
49. Hancock, R. E. W., & Lehrer, R. (1998). Cationic peptides: A new source of antibiotics. Trends in biotechnology, 16(2), 82-88. doi: 10.1016/S0167-7799(97)01156-6 PMID:9487736
50. Hansen, M., Kilk, K., & Langel, Ü. (2008). Predicting cell-penetrating peptides. Advanced Drug Delivery Reviews, 60(4-5), 572-579. doi: 10.1016/j.addr.2007.09.003 PMID:18045726
51. Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., & Zalipsky, S. (1997). Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochimica et Biophysica Acta, 1327(2), 181-192. doi: 10.1016/S0005-2736(97)00056-4 PMID:9271260
52. Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., & Vile, R. G. et al. (2001). Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. Annals of Oncology, 12(4), 493-496. doi: 10.1023/A:1011199028318 PMID:11398881
53. Harris, F., Dennison, S. R., & Phoenix, D. A. (2009). Anionic antimicrobial peptides from eukaryotic organisms. Current Protein & Peptide Science, 10(6), 585-606. doi: 10.2174/138920309789630589 PMID:19751192
54. Herce, H. D., Garcia, A. E., Litt, J., Kane, R. S., Martin, P., & Enrique, N. et al. (2009). Argininerich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophysical Journal, 97(7), 1917-925. doi: 10.1016/j.bpj.2009.05.066 PMID:19804722
55. Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009). Eleven years of Inflexal- a virosome adjuvanted influenza vaccine. Vaccine, 27(33), 4381-4387. doi: 10.1016/j.vaccine.2009.05.029 PMID:19450630
56. Höhne, G., Hemminger, W., & Flammersheim, H. J. (2003). Differential Scanning Calorimetry. 2 ed. New York: Springer. doi: 10.1007/978-3-662-06710-9
57. Holland, J. W., Hui, C., Cullis, P. R., & Madden, T. D. (1996). Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of hosphtidylethanolamine and phosphatidylserine. Biochemistry, 35(8), 2618-2624. doi: 10.1021/bi952000v PMID:8611565
58. Hu, J., Chen, C., Zhang, S., Zhao, X., Xu, H., Zhao, X., & Lu, J. R. (2011). Designed antimicrobial and antitumor peptides with high selectivity. Biomacromolecules, 12(11), 3839-3843. doi: 10.1021/bm201098j PMID:21955251
59. Huang, D. I. (2001). Mixed-chain phospholipids: Structures and chain-melting behavior. Lipids, 36(10), 1077-1097. doi: 10.1007/s11745-001-0818-1 PMID:11768152
60. Hunter, H., Jing, W., Schibli, D., Trinh, T., Park, I., Kim, S., & Vogel, H. (2005). The interactions of antimicrobial peptides derived from lysozyme with model membrane systems. Biochimica et Biophysica Acta, 1668(2), 175-189. doi: 10.1016/j.bbamem.2004.12.004 PMID:15737328
61. Immordino, M. L., Dosio, F., & Cattel, L. (2006). Stealth liposomes:a review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine, 1(3), 297-315. PMID:17717971
62. Ishida, E., Managit, C., Kawakami, S., Nishikawa, M., Yamashita, F., & Hashida, M. (2004). Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Pharmaceutical Research, 21(6), 932-939. doi: 10.1023/B:PHAM.0000029280.39882.ff PMID:15212156
63. Israelachvili, J. N. (2011). Intermolecular and Surface Forces. 3 ed. Acdemic Press.
64. Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006). Peptide antimicrobial agents. Clinical Microbiology Reviews, 19(3), 491-511. doi: 10.1128/CMR.00056-05 PMID:16847082
65. Jiang, Z.-H., & Koganty, R. (2003). Synthetic vaccine: The role of adjuvants in immune targeting. Current Medicinal Chemistry, 10(15), 1423-1439. doi: 10.2174/0929867033457340 PMID:12871139
66. Johanna, G., Baley, J., Haydee, G., Manfors, B., & Krause, D. (1994). Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates. Journal of Pediatric Infectious Disease, 13(1), 1-86.
67. Jones, M. N. (1995). The surface properties of phospholipid liposome systems and their characterization. Advances in Colloid and Interface Science, 54, 93-128. doi: 10.1016/0001-8686(94)00223-Y PMID:7832999
68. Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005). Glycopeptide and Lipoglycopeptide Antibiotics. Chemical Reviews, 105(2), 425-448. doi: 10.1021/cr030103a PMID:15700951
69. Keating, G. M., & Noble, S. (2003). Recombinant hepatitis B vaccine (Engerix B): A review of its immunogenicity and protective efficacy against hepatitis B. Drugs, 63(10), 1021-1051. PMID:12699402
70. Killian, J. A. (1998). Hydrophobic mismatch between proteins and lipids in membranes. Biochimica et Biophysica Acta, 1376(3), 401-415. doi: 10.1016/S0304-4157(98)00017-3 PMID:9805000
71. Lai, R., Liu, H., Hui Lee, W., & Zhang, Y. (2002). An anionic antimicrobial peptide from toad Bombina maxima. Biochemical and Biophysical Research Communications, 295(4), 796-799. doi: 10.1016/S0006-291X(02)00762-3 PMID:12127963
72. Laverty, G., Gorman, S. P., & Gilmore, B. F. (2011). The potential of antimicrobial peptides as biocides. International Journal of Molecular Sciences, 12(12), 6566-6596. doi: 10.3390/ijms12106566 PMID:22072905
73. Lentz, B. R. (1993). Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chemistry and Physics of Lipids, 64(1-3), 99-116. doi: 10.1016/0009-3084(93)90060-G PMID:8242843
74. Li, L. C., & Tian, Y. (2007). Zeta potential. Encyclopedia of Pharmaceutical Technology. Informa Healthcare.
75. Li, Y., Xiang, Q., Zhang, Q., Huang, Y., & Su, Z. (2012). Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and applications. Peptides, 37(2), 207-215. doi: 10.1016/j.peptides.2012.07.001 PMID:22800692
76. Lian, T., & Ho, R. J. Y. (2001). Trends and developments in liposome drug delivery systems. Journal of Pharmaceutical Sciences, 90(6), 667-680. doi: 10.1002/jps.1023 PMID:11357170
77. Lide, D. R. (2007) Handbook of chemistry and physics, 88ed, CRC Press, Boca Raton.
78. Lindgren, M., Hallbrink, M., Prochiantz, A., & Langel, U. (2000). Cell penetrating peptides. Trends in Pharmacological Sciences, 21(3), 99-103. doi: 10.1016/S0165-6147(00)01447-4 PMID:10689363
79. Liu, H. X., Zhang, R. S., Yao, X. J., Liu, M. C. M., Hu, Z. D., & Fan, B. J. (2004). Prediction of the isoelectric point of an amino acid based on GA-PLS and SVMs. Journal of Chemical Information and Computer Sciences, 44(1), 161-167. doi: 10.1021/ci034173u PMID:14741023
80. Lohner, K., Sevcsik,E., & Pabst, G. (2008). Liposome-based biomembrane mimetic systems: implications for lipid-peptide interactions. In Advances in Planar Lipid Bilayers and Liposomes, (pp. 103-132). Elsevier.
81. Lutsiak, M. E. C., Kwon, G. S., & Samuel, J. (2002). Analysis of peptide and lipopeptide content in liposomes. Journal of Pharmacy & Pharmaceutical Sciences, 5(3), 279-284. PMID:12553897
82. Maeda, N., Takeuchi, Y., Takada, M., Sadzuka, Y., Namba, Y., & Oku, N. (2004). Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. Journal of Controlled Release, 100(1), 41-52. doi: 10.1016/j.jconrel.2004.07.033 PMID:15491809
83. Marra, J., & Israelachvili, J. N. (1985). Direct Measurements of Forces between Phosphatidylcholine and Phosphatidylethanolamine Bilayers in Aqueous Electrolyte Solutions. Biochemistry, 24(17), 4608-4618. doi: 10.1021/bi00338a020 PMID:4063343
84. Matos, C., de Castro, B., Gameiro, P., Lima, J. L. F. C., & Reis, S. (2004). Zeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomes. Langmuir, 20(2), 369-377. doi: 10.1021/la034780b PMID:15743080
85. Matsuzaki, K. (1999). Why and how are peptidelipid interactions utilized for self-defense? Margainins and tachyplesins as archetypes. Biochimica et Biophysica Acta, 1462(1-2), 1-10. doi: 10.1016/S0005-2736(99)00197-2 PMID:10590299
86. McManus, P. S., Stockwell, V. O., Sundin, G. W., & Jone, A. L. (2002). Antibiotic use on plant agriculture. Annual Review of Phytopathology, 40(1), 443-465. doi: 10.1146/annurev.phyto.40.120301.093927 PMID:12147767
87. Mcphee, J. B., & Hancock, R. E. (2005). Function and therapeutic potential of host defence peptides. Journal of Peptide Science, 11(11), 677-687. doi: 10.1002/psc.704 PMID:16103989
88. Mischler, R., & Metcalfe, I. C. (2002). Inflexal a trivalent virosome subunit influenza vaccine:production. Vaccine, 20(5), B17-23. doi: 10.1016/S0264-410X(02)00512-1 PMID:12477413
89. Molnár, I., & Horvath, C. (1977). Separation of amino acids and peptides on non-polar stationary phases by high performance liquid chromatography. Journal of chromatography, 142, 623-640. doi: 10.1016/S0021-9673(01)92073-4 PMID:914939
90. Monera, O. D., Sereda, T. J., Zhou, N. E., Kay, C. M., & Hodges, R. S. (1995). Relationship of sidechain hydrophobicity and α-helical propensity on the stability of the single-stranded amphipathic α-Helix. Journal of Peptide Science, 1(5), 319-329. doi: 10.1002/psc.310010507 PMID:9223011
91. Moore, D. (1985). Amino acid and peptide net charges: A simple calculational procedure. Biochemical Education, 13(1), 10-11. doi: 10.1016/0307-4412(85)90114-1
92. Morley, P. S., Apley, M. D., Besser, T. E., Burney, D. P., Fedorka-Cray, P. J., & Papich, M. G. et al. (2005). Antimicrobial Drug Use in Veterinary Medicine. Journal of Veterinary Internal Medicine, 19(4), 617-629. doi: 10.1111/j.1939-1676.2005.tb02739.x PMID:16095186
93. Nardin, E. (2010). The past decade in malaria synthetic peptide vaccine clinical trials. Human Vaccines, 6(1), 27-38. doi: 10.4161/hv.6.1.9601 PMID:20173408
94. Nelson, D. A., Piran, T., & Weinberg, S. (2004). Statistical mechanics of membranes and surfaces (2nd ed.). World Scientific Publishing Co.
95. Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011). The expanding scope of antimicrobial peptide structures and their modes of actions. Trends in Biotechnology, 29(9), 464-472. doi: 10.1016/j.tibtech.2011.05.001 PMID:21680034
96. Noah,D., Fidas,G. (2000). The Global Infectious Disease Threat and its Implications for the United States. Accession Number ADA502015
97. Olson, F., Hunt, C. A., Szoka, F. C., Vail, W. J., & Papahadjopoulos, D. (1979). Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochimica et Biophysica Acta, 557(1), 9-23. doi: 10.1016/0005-2736(79)90085-3 PMID:95096
98. Panduranga Rao, K. (1995). Recent developments of collagen-based materials for medical applications and drug delivery systems. Journal of Biomaterials Science, 7(7), 623-645. doi: 10.1163/156856295X00526 PMID:8924427
99. Parker, C. A., & Rees, W. T. (1962). Fluorescence spectrometry: A review. Analyst (London), 87(1031), 83-111. doi: 10.1039/an9628700083
100. Pedersen, T. B., Sabra, M. C., Frokjaer, S., Mouritsen, O. G., & Jorgensen, K. (2001). Association of acylated cationic decapeptides with dipalmitoylphosphatidylserine-dipalmitoylphosphatidylcholine lipid membranes. Chemistry and Physics of Lipids, 113(1-2), 83-95. doi: 10.1016/S0009-3084(01)00177-3 PMID:11687229
101. Pencer, J., & Hallett, F. R. (2003). Effects of vesicle size and shape on static and dynamic light scattering measurements. Langmuir, 19(18), 7488-7497. doi: 10.1021/la0345439
102. Reinish, L. W., Bally, M. B., Loughrey, H. C., & Cullis, P. R. (1988). Interaction of liposomes and platelets. Thrombosis and Haemostasis, 60(3), 518-523. PMID:3238654
103. Reuter, M., Schwieger, C., Meister, A., Karlsson, G., & Blume, A. (2009). Poly-L-lysines and poly-L-arginines induce leakage of negatively charged phospholipid vesicles and translocate through the lipid bilayer upon electrostatic binding to the membrane. Biophysical Chemistry, 144(1-2), 27-37. doi: 10.1016/j.bpc.2009.06.002 PMID:19560854
104. Rex, S. (1996). Pore formation induced by the peptide melittin in different lipid vesicle membranes. Biophysical Chemistry, 58(1-2), 75-85. doi: 10.1016/0301-4622(95)00087-9 PMID:8679920
105. Rex, S., & Schwarz, G. (1998). Quantitative studies on the melittin-induced leakage mechanism of lipid vesicles. Biochemistry, 37(8), 2336-2345. doi: 10.1021/bi971009p PMID:9485380
106. Ricci, M., Giovagnoli, S., Blasi, P., Schoubben, A., Perioli, L., & Rossi, C. (2006). Development of liposomal capreomycin sulfate formulations: Effects of formulation variables on peptide encapsulation. International Journal of Pharmaceutics, 311(1-2), 172-181. doi: 10.1016/j.ijpharm.2005.12.031 PMID:16439072
107. Rinaldi, A. C. (2002). Antimicrobial peptides from amphibian skin: An expanding scenario. Current Opinion in Chemical Biology, 6(6), 799-804. doi: 10.1016/S1367-5931(02)00401-5 PMID:12470734
108. Riske, K. A., Barroso, R. P., Vequi-suplicy, C. C., Germano, R., Henriques, V. B., & Lamy, M. T. (2009). Lipid bilayer pre-transition as the beginning of the melting process. Biochimica et Biophysica Acta, 1788(5), 954-963. doi: 10.1016/j.bbamem.2009.01.007 PMID:19366598
109. Schroeder, A., Kost, J., & Barenholz, Y. (2009). Ultrasound, liposomes, and drug delivery: Principles for using ultrasound to control the release of drugs from liposomes. Chemistry and Physics of Lipids, 162(1-2), 1-16. doi: 10.1016/j.chemphyslip.2009.08.003 PMID:19703435
110. Schwendener, R. A., Ludewig, B., Cerny, A., & Engler, O. (2010). Liposome-based vaccines. Methods in Molecular Biology (Clifton, N.J.), 605, 163-175. doi: 10.1007/978-1-60327-360-2_11 PMID:20072880
111. Sette, A., & Fikes, J. (2003). Epitope-based vaccine: An update on epitope identification, vaccine design and delivery. Current Opinion in Immunology, 15(4), 461-470. doi: 10.1016/S0952-7915(03)00083-9 PMID:12900280
112. Shek, P. N., & Sabiston, B. H. (1982). Immune response mediated by liposome-associated protein antigens.I.Potentiation of the plaque-forming cell response. Immunology, 45(2), 349-356. PMID:7037620
113. Spohn, G., & Bachmann, M. F. (2008). Expoliting viral properties for the rational design of modern vaccine. Expert Review of Vaccines, 7(1), 43. doi: 10.1586/14760584.7.1.43 PMID:18251693
114. Stewart, K. M., Horton, K. L., & Kelley, S. O. (2008). Cell-penetrating peptides as delivery vehicles for biology and medicine. Organic & Biomolecular Chemistry, 6(13),2 242-255. doi: 10.1039/b719950c PMID:18563254
115. Goñi, F. M., & Alonso, A. (1999). Structure and functional properties of diacylglycerols in membranes. Progress in Lipid Research, 38, 1-48. PMID:10396601
116. Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., & Laverman, P. et al. (2002). Role of complement activation in hypersensitivity reactions to DOXIL and hynic PEG liposomes:experimental and clinical studies. Journal of Liposome Research, 12(1-2), 165-172. doi: 10.1081/LPR-120004790 PMID:12604051
117. Taylor, T. M., Gaysinsky, S., Davidson, P. M., Bruce, B. D., & Weiss, J. (2007). Characterization of antimicrobial-bearing liposomes by ξ-potential, vesicle size, and encapsulation efficiency. Food Biophysics, 2(1), 1-9. doi: 10.1007/s11483-007-9023-x
118. Thorén, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A., & Norden, B. (2003). Uptake of analogs of penetratin, Tat (48-60) and oligoarginine in live cells. Biochemical and Biophysical Research Communications, 307(1), 100-107. doi: 10.1016/S0006-291X(03)01135-5 PMID:12849987
119. Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature reviews. Drug discovery, 4, 145-160. PMID:15688077
120. Torrens, F., Castellano, G., Campos, A., & Abad, C. (2007). Negatively cooperative binding of melittin to neutral phsophsolipid vesicles. Journal of Molecular Structure, 834-836, 216-228. doi: 10.1016/j.molstruc.2006.11.052
121. Uhumwangho, M. U., & Okor, R. S. (2005). Current trends in the production and biomedical applications of liposomes: A review. Journal of Biomedical Science, 4(1), 9-21.
122. Ulijn, R. V., & Smith, A. M. (2008). Designing peptide based nanomaterials. Chemical Society Reviews, 37(4), 664-675. doi: 10.1039/b609047h PMID:18362975
123. Vemuri, S., & Rhodes, C. T. (1995). Preparation and characterization of liposomes as therapeutic delivery ystems:a review. Pharmaceutica Acta Helvetiae, 70(2), 95-111. doi: 10.1016/0031-6865(95)00010-7 PMID:7651973
124. Wu, M., Maier, E., Benz, R., & Hancock, E. W. (1999). Mechanism of Interaction of Different Classes of Cationic Antimicrobial Peptides with Planar Bilayers and with the Cytoplasmic Membrane of Escherichia coli. Biochemistry, 38(22), 7235-7242. doi: 10.1021/bi9826299 PMID:10353835
125. Xu, X., & Burgess, D. J. (2012). Liposomes as carriers for controlled drug delivery. In J. C. Wright, & D. J. Burgess (Eds.), Long acting injections and implants (pp. 195-220). Springer, US. doi: 10.1007/978-1-4614-0554-2_11
126. Ye, G., Gupta, A., DeLuca, R., Parang, K., & Bothun, G. D. (2010). Bilayer disruption and liposome restructuring by a homologous series of small Arg. Rich synthetic peptides. Colloids and Surfaces. B, Biointerfaces, 76(1), 76-81. doi: 10.1016/j.colsurfb.2009.10.016 PMID:19913394
127. Yeagle, P. L. (2005). The Structure of Biological Membranes. Boca Raton: CRC Press.
128. Yeaman, M. R., & Yount, N. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacological Reviews, 55(1), 27-55. doi: 10.1124/pr.55.1.2 PMID:12615953
129. Zaiou, M. (2007). Multifunctional antimicrobial peptides: Therapeutic targets in several human diseases. Journal of Molecular Medicine, 85(4), 317-329. doi: 10.1007/s00109-006-0143-4 PMID:17216206
130. Zepp, F. (2010). Principles of vaccine design-lessons from nature. Vaccine, 28(3), C14-24. doi: 10.1016/j.vaccine.2010.07.020 PMID:20713252
131. Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., & Lagacé-Wiens, P. R. S. et al. (2010). New Lipoglycopeptides. Drugs, 70(7), 859-886. doi: 10.2165/11534440-000000000-00000 PMID:20426497
132. Zhang, L., Rozek, A., & Hancock, R. E. W. (2001). Interaction of Cationic Antimicrobial Peptides with Model Membranes. The Journal of Biological Chemistry, 276(38), 35714-35722. doi: 10.1074/jbc.M104925200 PMID:11473117
133. Ziegler, A., Blatter, X. L., & Seelig, J. (2003). Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles, binding mechanism and thermodynamic analysis. Biochemistry, 42(30), 9185-194. doi: 10.1021/bi0346805 PMID:12885253